國立虎尾科技大學 |

Colitis-Associated Cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Colitis-Associated Cancer/ edited by Masato Kusunoki.
other author:	Kusunoki, Masato.
Description:	VIII, 150 p. 21 illus., 15 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Surgery. -
Online resource:	https://doi.org/10.1007/978-4-431-55522-3
ISBN:	9784431555223

Colitis-Associated Cancer
Colitis-Associated Cancer[electronic resource] /edited by Masato Kusunoki. - 1st ed. 2016. - VIII, 150 p. 21 illus., 15 illus. in color.online resource.

Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn’s Disease.

As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn’s disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn’s disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.

ISBN: 9784431555223

Standard No.: 10.1007/978-4-431-55522-3doiSubjects--Topical Terms:

644132
Surgery.

LC Class. No.: RD1-811

Dewey Class. No.: 617

Colitis-Associated Cancer
LDR:02885nam a22003975i 4500 001 978385
003 DE-He213
005 20200701021724.0
007 cr nn 008mamaa
008 201211s2016 ja | s |||| 0|eng d
020 $a 9784431555223 $9 978-4-431-55522-3
024 7 $a 10.1007/978-4-431-55522-3 $2 doi
035 $a 978-4-431-55522-3
050 4 $a RD1-811
072 7 $a MN $2 bicssc
072 7 $a MED085000 $2 bisacsh
072 7 $a MN $2 thema
082 0 4 $a 617 $2 23
245 1 0 $a Colitis-Associated Cancer $h [electronic resource] / $c edited by Masato Kusunoki.
250 $a 1st ed. 2016.
264 1 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a VIII, 150 p. 21 illus., 15 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn’s Disease.
520 $a As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn’s disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn’s disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
650 0 $a Surgery. $3 644132
650 0 $a Surgical oncology. $3 1254222
650 0 $a Cancer research. $3 1253664
650 0 $a Medical genetics. $3 678508
650 2 4 $a Surgical Oncology. $3 673742
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Gene Function. $3 782134
700 1 $a Kusunoki, Masato. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1103253
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9784431555216
776 0 8 $i Printed edition: $z 9784431555230
776 0 8 $i Printed edition: $z 9784431563037
856 4 0 $u https://doi.org/10.1007/978-4-431-55522-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)